Australia, June 23 -- Absci Corp., owns the trademark (2608990) for 'HEADLINE' till Dec. 3, 2035.
Status: registered:
Registered/protected
Classes: 5 [biological preparations for medical research purposes; Cells for medical or clinical use; antibodies for the treatment of inflammatory and fibrotic diseases], 42 [Medical and scientific research in the field of antibodies], 5 [biological preparations for medical research purposes;Cells for medical or clinical use;antibodies for the treatment of inflammatory and fibrotic diseases] and 42 [Medical and scientific research in the field of antibodies]
Type of Mark: Word
Date of Acceptance: Dec. 8, 2025
Registration Advertised: June 22
For further details contact PHILLIPS ORMONDE FITZPATRICK.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2608990.
Disclaimer: Curated by HT Syndication.
